BG104839A - Chrystalline form of paroxetine - Google Patents

Chrystalline form of paroxetine

Info

Publication number: BG104839A
Authority: BG; Bulgaria
Prior art keywords: paroxetine; chrystalline; free; therapy; pure
Prior art date: 1998-03-16

Application number

BG104839A

Other languages

Bulgarian (bg)

English (en)

Inventor

Andrew Craig

Neal Ward

WAINE Wilson McIL

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-16

Filing date

2000-10-11

Publication date

2001-09-28

1998-03-16 Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en

1998-06-17 Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en

1998-08-06 Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en

2000-10-11 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2001-09-28 Publication of BG104839A publication Critical patent/BG104839A/xx

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 2
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 2
229960002296 paroxetine Drugs 0.000 title abstract 2
239000012458 free base Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BG104839A 1998-03-16 2000-10-11 Chrystalline form of paroxetine BG104839A (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9805581.7A GB9805581D0 (en)	1998-03-16	1998-03-16	Novel compounds
GBGB9813054.5A GB9813054D0 (en)	1998-06-17	1998-06-17	Novel compounds
GBGB9817115.0A GB9817115D0 (en)	1998-08-06	1998-08-06	Novel compounds
PCT/GB1999/000793 WO1999047519A1 (en)	1998-03-16	1999-03-16	Crystalline form of paroxetine

Publications (1)

Publication Number	Publication Date
BG104839A true BG104839A (en)	2001-09-28

Family

ID=27269245

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104839A BG104839A (en)	1998-03-16	2000-10-11	Chrystalline form of paroxetine

Country Status (18)

Country	Link
EP (1)	EP1064282A1 (id)
JP (1)	JP2002506865A (id)
KR (1)	KR20010041947A (id)
CN (1)	CN1300286A (id)
AP (1)	AP2000001907A0 (id)
AU (1)	AU2847199A (id)
BG (1)	BG104839A (id)
BR (1)	BR9908825A (id)
CA (1)	CA2323896A1 (id)
EA (1)	EA200000946A1 (id)
HU (1)	HUP0101215A3 (id)
ID (1)	ID27596A (id)
IL (1)	IL138390A0 (id)
NO (1)	NO20004583L (id)
PL (1)	PL342931A1 (id)
SK (1)	SK13622000A3 (id)
TR (1)	TR200002675T2 (id)
WO (1)	WO1999047519A1 (id)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) *	1999-08-12	1999-10-13	Smithkline Beecham Plc	Novel compound composition and process
US20080033050A1 (en)	2006-08-04	2008-02-07	Richards Patricia Allison Tewe	Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
EP0223403B1 (en) *	1985-10-25	1993-08-04	Beecham Group Plc	Piperidine derivative, its preparation, and its use as medicament
SK283608B6 (sk) *	1995-02-06	2003-10-07	Smithkline Beecham Plc	Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie

1999
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Withdrawn
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Ceased
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown

Also Published As

Publication number	Publication date
EP1064282A1 (en)	2001-01-03
SK13622000A3 (sk)	2001-03-12
WO1999047519A1 (en)	1999-09-23
BR9908825A (pt)	2000-11-21
CN1300286A (zh)	2001-06-20
PL342931A1 (en)	2001-07-16
AP2000001907A0 (en)	2000-09-30
TR200002675T2 (tr)	2000-12-21
IL138390A0 (en)	2001-10-31
KR20010041947A (ko)	2001-05-25
EA200000946A1 (ru)	2001-02-26
NO20004583D0 (no)	2000-09-14
HUP0101215A3 (en)	2002-05-28
JP2002506865A (ja)	2002-03-05
CA2323896A1 (en)	1999-09-23
ID27596A (id)	2001-04-12
AU2847199A (en)	1999-10-11
NO20004583L (no)	2000-09-15
HUP0101215A2 (hu)	2002-04-29

Similar Documents

Publication	Publication Date	Title
MY135732A (en)	2008-06-30	5,6-trimethylenepyrimidin - 4 - one compounds
MY114014A (en)	2002-07-31	Imidazole compounds, compositions and use
HU9503605D0 (en)	1996-02-28	Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
PL327735A1 (en)	1998-12-21	Novel substituted derivatives of imidazole
PL327934A1 (en)	1999-01-04	Novel substituted imidazole compounds
SI0882021T1 (en)	2003-10-31	New phenanthridines
PL349028A1 (en)	2002-07-01	Cancer treatment composition and method using natural plant essential oils
ZA975443B (en)	1998-02-10	Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides.
AU2291097A (en)	1997-10-17	Novel phenanthridines substituted in the 6 position
AU5186799A (en)	2000-02-07	Peptides of il-2 and derivatives thereof and their use as therapeutic agents
YU13301A (sh)	2005-06-10	Muskarinski agonisti i antagonisti
HU229458B1 (en)	2013-12-30	Pharmaceutical compositions containing zolmitriptan
PL340561A1 (en)	2001-02-12	Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders
PL316656A1 (en)	1997-02-03	Free halophantrin base for use in treating marsh-fever and compositions containing same
NZ335078A (en)	2000-10-27	Composition, for the treatment of asthma, containing loratadine and a decongestant
AU2982495A (en)	1996-02-16	Heterocycle-condensed morphinoid derivatives
BG105204A (en)	2001-11-30	Salts of paroxetine
MX9707875A (es)	1997-11-29	Levobupivacaina y su uso como un anestesico en mujeres embarazadas.
MY127675A (en)	2006-12-29	Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
IL106237A0 (en)	1993-11-15	Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
BG104839A (en)	2001-09-28	Chrystalline form of paroxetine
GEP20043313B (en)	2004-03-10	Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility
BG104914A (en)	2001-10-31	Paroxetine maleate
GB9626472D0 (en)	1997-02-05	New use of comt inhibitors
AU4944899A (en)	2000-02-01	New pharmaceutically active compounds